Menu
Menu
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership focused on advancing biopharmaceutical manufacturing, solving industry challenges, and developing the skilled workforce of the future.
The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.
NIIMBL will lead and transform the development and adoption of next-generation biopharmaceutical manufacturing technologies that contribute to patient well-being. As a public–private partnership, NIIMBL will forge and catalyze advancements that are vital to the acceleration of innovative technologies and a skilled workforce, and these strategic efforts and investments will be undertaken to secure U.S. biopharmaceutical manufacturing leadership.
NIIMBL is made up of a diverse set of stakeholders, including:
Members have the opportunity to collectively revolutionize current biomanufacturing platforms, processes, and educational programs and share in the benefits of these transformative solutions.
As of June 30, 2023
NIIMBL is a proud member of Manufacturing USA®, a diverse network of federally sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.
Together with our partners from industry, academia, non-profits, and government agencies, we:
Collaborate on innovative manufacturing technologies that accelerate the ability to bring life-saving and life-enhancing products to market
Help companies find ways to adopt and implement new technologies and approaches, enhancing patient access to medicines and vaccines
Cultivate a world-leading biopharmaceutical workforce through novel training and education programs
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
The NIIMBL ecosystem’s collaborative efforts to accelerate innovative manufacturing technologies help to:
Promote economic development and enhanced national security
Increase the biopharmaceutical industry’s global competitiveness
Bring life-saving and life-enhancing products to market faster and at reduced cost, while maintaining safety and efficacy
Ensure a secure, integrated supply chain
Meet the workforce development needs of the biopharmaceutical manufacturing ecosystem
Hear what our members have to say:
NIIMBL gives us a great platform to share pre-competitively
Narendra Bam
Senior Vice President, Medicine Development and Supply
GlaxoSmithKline
Collaborations accelerate our innovation
Andy Wirths
Senior Vice President of America Supply Region
AstraZeneca
Ensuring we’re able to educate and develop the biopharmaceutical manufacturing workforce right here in the U.S.
David Elkins
Executive Vice President and Chief Financial Officer
Bristol Myers Squibb™
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
Executive Director
Director, Business Operations
Director, Sponsored Programs
Institute Director
Director, Business Development
NIIMBL’s national meeting is an exclusive member-only event offering inspiring plenaries, engaging sessions, and thought-provoking conversations. It affords NIIMBL membership the opportunity to both celebrate our accomplishments and plan for the future.
Feedback from the 2023 National Meeting: